Indianapolis, IN, United States of America

Christopher Randall Schmid



Average Co-Inventor Count = 1.9

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1992-2011

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Christopher Randall Schmid: Innovator in Pharmaceutical Chemistry

Introduction

Christopher Randall Schmid is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work primarily focuses on developing innovative compounds that serve as therapeutic agents.

Latest Patents

Among his latest patents, Schmid has developed inhibitors of AKT (protein kinase B), specifically the compound 4-[5-(2-Amino-ethanesulfonyl)-isoquinolin-7-yl]-phenol. This compound, along with its pharmaceutically acceptable salts and hydrates, is recognized for its potential as antineoplastic and/or antiviral agents. Additionally, he has worked on peroxisome proliferator-activated receptor alpha agonists, which include a range of compounds characterized by specific structural formulas and functional groups. These inventions aim to provide new therapeutic options for various medical conditions.

Career Highlights

Christopher Schmid is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves extensive research and development in the field of drug discovery and formulation. His innovative approach and dedication to advancing pharmaceutical science have positioned him as a key contributor in his field.

Collaborations

Throughout his career, Schmid has collaborated with several talented individuals, including James Patrick Sluka and Kristin Sue Marron. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Christopher Randall Schmid is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic agents. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…